HMN 2025: Modified mRNA vaccine masquerades as a virus to trick the physique into stronger immunity

A more practical vaccine expertise could also be on the horizon. In a brand new study in mice, researchers from the University of Copenhagen exhibit {that a} easy addition to mRNA vaccines can considerably improve their effectiveness. The innovation might turn out to be a robust instrument within the subsequent pandemic. The subsequent step is human trials.

During the COVID-19 pandemic, it wasn’t simply face masks that turned a part of on a regular basis dialog—so did a brand new vaccine expertise: the mRNA vaccine.

As the primary of its type, the COVID-19 vaccine was developed utilizing mRNA expertise, which proved each extremely efficient in opposition to the virus and fast to adapt to new variants. However, the immunity supplied by mRNA vaccines tends to wane quickly, leaving individuals susceptible to reinfection simply months after vaccination.

Now, a workforce of researchers might have discovered an answer.

In a brand new study published in Nature Nanotechnology, scientists from the University of Copenhagen and the biotech firm AdaptVac—initially a spinout from the college—present that mice develop a stronger and longer-lasting immune response when the mRNA vaccine is disguised as virus-like particles.

“Our study combines two applied sciences: mRNA vaccines and what we name virus-like particles. By engineering the mRNA vaccine to supply virus-like particles, we trick the immune system into considering it is encountering an actual virus. This triggers a a lot stronger and extra sturdy immune response in mice, which is precisely what we wish,” says lead writer Cyrielle Fougeroux, Senior Scientist at AdaptVac.

A vaccine in viral disguise

The researchers exhibit that by including an additional genetic sequence to the prevailing mRNA vaccine, they will immediate the immune system to mount a extra highly effective and sustained response. This implies that decrease doses could also be enough, and the research additionally means that the vaccine’s results last more.

“We consider this discovery represents a big enchancment to present mRNA expertise and will play a serious function within the improvement of next-generation vaccines,” says senior writer Adam Sander, Professor on the Department of Immunology and Microbiology on the University of Copenhagen and Scientific Director at AdaptVac.

While it stays to be seen how a lot the brand new mRNA vaccine expertise can lengthen immune responses in people, the mouse research present a considerably stronger and longer-lasting immunity.

Preparing for the subsequent pandemic

Researchers around the globe are working to raised put together for future pandemics. mRNA vaccines are anticipated to stay a key a part of the worldwide response to rising viruses.

At the University of Copenhagen, Sander and his colleagues are creating a vaccine in opposition to the Nipah virus, which is on the WHO’s checklist of potential future pandemic threats. The new expertise is anticipated to be prepared for human testing inside the subsequent few years.

“mRNA expertise is a robust instrument in opposition to a variety of illnesses, however its short-lived impact in people is a serious problem. If we are able to use virus-like particles to realize a stronger and probably longer-lasting immune response, we have made a significant enchancment to the expertise—one that might have a serious impression throughout a pandemic,” says Sander.

In sensible phrases, this might imply fewer and smaller vaccine doses are wanted to take care of immunity—saving each cash and well being care assets.

When mRNA vaccines emerged in the course of the COVID-19 pandemic, they marked a serious shift from conventional vaccine improvement. Previously, vaccines had been made utilizing lab-produced antigens from both reside or inactivated viruses—a gradual course of that struggles to maintain tempo with quickly mutating pathogens.

mRNA vaccines work otherwise: The antigen is produced contained in the physique. The vaccine itself consists of a small piece of genetic code—messenger RNA (mRNA)—to which the immune system responds.

In this study, researchers added a second genetic sequence to the traditional mRNA vaccine. One sequence instructs the physique to supply the vaccine antigen, whereas the opposite codes for a virus-like particle. Inside the physique’s cells, the 2 elements assemble into virus-like particles with surfaces densely coated within the vaccine antigen.

To the immune system, the end result seems to be like an actual virus—triggering a stronger immune response.